National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Colistimethate sodium (colobreathe®) is indicated for the management of chronic pulmonary infections due to Pseudomonas aeruginosa in patients with cystic fibrosis (CF) aged 6 years and older.

Rapid Review

Commenced Completed Outcome
07/06/2013 28/06/2013 Full Pharmacoeconomic Evaluation Not Recommended